4//SEC Filing
KEMPF DAVID A 4
Accession 0001011034-09-000069
CIK 0001443062other
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 5:32 PM ET
Size
14.2 KB
Accession
0001011034-09-000069
Insider Transaction Report
Form 4
KEMPF DAVID A
DirectorCOO/CFO
Transactions
- Purchase
Series A Convertible Preferred Stock
2009-06-17$1.00/sh+7,500$7,500→ 316,667 totalExercise: $0.75From: 2009-06-17→ common stock (10,000 underlying) - Purchase
warrants
2009-06-17+3,750→ 320,417 totalExercise: $1.50From: 2009-06-17Exp: 2010-12-17→ common stock (3,750 underlying)
Holdings
- 2,800(indirect: By IRA)
Common Stock
- 300,000
options
Exercise: $1.00From: 2012-02-11Exp: 2019-02-11→ common stock (100,000 underlying) - 100,000
Options
Exercise: $1.00From: 2010-02-11Exp: 2019-02-11→ Common Stock (100,000 underlying) - 200,000
Options
Exercise: $1.00From: 2011-02-11Exp: 2019-02-11→ common stock (100,000 underlying) - 3,000(indirect: By IRA)
Common Stock
- 306,667
Series A Convertible Preferred Stock
Exercise: $0.75From: 2009-04-15→ common stock (6,667 underlying)
Footnotes (1)
- [F1]not applicable
Documents
Issuer
BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC
CIK 0001443062
Entity typeother
Related Parties
1- filerCIK 0001458510
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 5:32 PM ET
- Size
- 14.2 KB